BioMarin Pharmaceutical ROE 2006-2018 | BMRN

Current and historical return on equity (ROE) values for BioMarin Pharmaceutical (BMRN) over the last 10 years.
BioMarin Pharmaceutical Annual ROE - Return on Equity
2017 -4.17
2016 -22.78
2015 -7.16
2014 -8.77
2013 -13.15
2012 -11.26
2011 -6.96
2010 28.70
2009 -0.15
2008 11.14
2007 -8.42
2006 -24.22
2005 95.88
BioMarin Pharmaceutical Quarterly ROE - Return on Equity
Q2 2018 -0.58
Q1 2018 -1.57
Q4 2017 -1.83
Q3 2017 -0.45
Q2 2017 -1.32
Q1 2017 -0.59
Q4 2016 -3.28
Q3 2016 -1.42
Q2 2016 -21.85
Q1 2016 -3.63
Q4 2015 2.86
Q3 2015 -3.97
Q2 2015 -3.48
Q1 2015 -2.78
Q4 2014 -4.57
Q3 2014 0.49
Q2 2014 -2.29
Q1 2014 -2.61
Q4 2013 -4.62
Q3 2013 -4.15
Q2 2013 -1.71
Q1 2013 -3.18
Q4 2012 -5.22
Q3 2012 -0.53
Q2 2012 -3.20
Q1 2012 -3.11
Q4 2011 -3.46
Q3 2011 -2.28
Q2 2011 -0.69
Q1 2011 -0.61
Q4 2010 -1.70
Q3 2010 37.11
Q2 2010 -0.13
Q1 2010 0.33
Q4 2009 1.46
Q3 2009 2.19
Q2 2009 0.46
Q1 2009 -4.80
Q4 2008 8.86
Q3 2008 0.35
Q2 2008 1.69
Q1 2008 0.81
Q4 2007 1.37
Q3 2007 -2.99
Q2 2007 -2.31
Q1 2007 -5.64
Q4 2006 4.85
Q3 2006 -5.76
Q2 2006 -2.71
Q1 2006 -21.26
Q4 2005 -1.04
Q3 2005 23.67
Q2 2005 19.32
Q1 2005 24.89
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $18.317B $1.314B
BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment of mucopolysaccharidosis-I, or MPS-I. Patients were treated with BM101 as part of a pivotal clinical trial completed to determine the safety and efficacy of the drug in humans.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $126.710B 14.54
Gilead Sciences (GILD) United States $100.220B 11.12
Biogen (BIIB) United States $69.222B 14.67
Celgene (CELG) United States $65.209B 13.02
Illumina (ILMN) United States $48.535B 60.81
Vertex Pharmaceuticals (VRTX) United States $44.961B 102.29
Regeneron Pharmaceuticals (REGN) United States $39.573B 22.25
Alexion Pharmaceuticals (ALXN) United States $26.672B 20.05
Incyte (INCY) United States $14.126B 474.64
Seattle Genetics (SGEN) United States $11.851B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.380B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.361B 60.17
BeiGene (BGNE) Cayman Islands $8.817B 0.00
QIAGEN (QGEN) Netherlands $8.650B 28.28
Bluebird Bio (BLUE) United States $8.470B 0.00
Sarepta Therapeutics (SRPT) United States $8.297B 0.00
Alkermes (ALKS) Ireland $6.904B 0.00
Bio-Techne Corp (TECH) United States $6.769B 45.49
Exact Sciences (EXAS) United States $6.116B 0.00
Exelixis (EXEL) United States $5.925B 19.30
Galapagos (GLPG) Belgium $5.475B 0.00
Ligand Pharmaceuticals (LGND) United States $5.257B 46.56
Ultragenyx Pharmaceutical (RARE) United States $3.838B 0.00
Immunomedics (IMMU) United States $3.760B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.601B 0.00
Horizon Pharma Public (HZNP) Ireland $3.423B 19.38
Intercept Pharmaceuticals (ICPT) United States $3.301B 0.00
Akcea Therapeutics (AKCA) United States $3.202B 0.00
China Biologic Products (CBPO) China $3.150B 20.81
Blueprint Medicines (BPMC) United States $3.124B 0.00
Array BioPharma (ARRY) United States $3.006B 0.00
Myriad Genetics (MYGN) United States $2.974B 35.58
Medicines (MDCO) United States $2.943B 0.00
Emergent Biosolutions (EBS) United States $2.882B 22.96
Ascendis Pharma (ASND) Denmark $2.824B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.814B 0.00
Amicus Therapeutics (FOLD) United States $2.633B 0.00
Halozyme Therapeutics (HALO) United States $2.517B 33.54
Global Blood Therapeutics (GBT) United States $2.415B 0.00
Spark Therapeutics (ONCE) United States $2.305B 0.00
CRISPR THERAPTC (CRSP) Switzerland $2.278B 0.00
MyoKardia (MYOK) United States $2.265B 0.00
Acceleron Pharma (XLRN) United States $2.191B 0.00
Repligen (RGEN) United States $2.168B 72.79
REGENXBIO (RGNX) United States $2.123B 33.35
Cambrex (CBM) United States $2.019B 16.19
Momenta Pharmaceuticals (MNTA) United States $2.005B 0.00
AnaptysBio (ANAB) United States $1.996B 0.00
G1 THERAPEUTICS (GTHX) United States $1.906B 0.00
Genomic Health (GHDX) United States $1.898B 105.86
Mirati Therapeutics (MRTX) United States $1.888B 0.00
Arena Pharmaceuticals (ARNA) United States $1.820B 0.00
Clovis Oncology (CLVS) United States $1.819B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.795B 0.00
ACADIA Pharmaceuticals (ACAD) United States $1.791B 0.00
Atara Biotherapeutics (ATRA) United States $1.746B 0.00
Rubius Therapeutics (RUBY) United States $1.726B 0.00
Reata Pharmaceuticals (RETA) United States $1.713B 0.00
Puma Biotechnology (PBYI) United States $1.705B 0.00
Aimmune Therapeutics (AIMT) United States $1.654B 0.00
Sangamo Therapeutics (SGMO) United States $1.652B 0.00
Allakos (ALLK) United States $1.622B 0.00
Insmed (INSM) United States $1.619B 0.00
Lion Biotechnologies (IOVA) United States $1.525B 0.00
Myovant Sciences (MYOV) United Kingdom $1.455B 0.00
Innoviva (INVA) United States $1.428B 9.16
Denali Therapeutics (DNLI) United States $1.427B 0.00
IMMURON LTD (IMRN) Australia $1.427B 0.00
Editas Medicine (EDIT) United States $1.411B 0.00
Solid Biosciences (SLDB) United States $1.383B 0.00
WAVE Life Sciences (WVE) Singapore $1.356B 0.00
Acorda Therapeutics (ACOR) United States $1.351B 28.17
UniQure (QURE) Netherlands $1.349B 0.00
Coherus BioSciences (CHRS) United States $1.316B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.299B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.296B 0.00
BIOHAVEN PHARM (BHVN) United States $1.275B 0.00
Audentes Therapeutics (BOLD) United States $1.246B 0.00
Intellia Therapeutics (NTLA) United States $1.205B 0.00
Cellectis (CLLS) France $1.183B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.154B 0.00
Intra-Cellular Therapies (ITCI) United States $1.138B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.131B 2160.00
Zai Lab Unsponsored ADR (ZLAB) China $1.109B 0.00
DBV Technologies (DBVT) France $1.095B 0.00
Retrophin (RTRX) United States $1.086B 0.00
Athenex (ATNX) United States $1.081B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.073B 0.00
NeoGenomics (NEO) United States $1.033B 180.71
CytomX Therapeutics (CTMX) United States $1.014B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.014B 0.00
Apellis Pharmaceuticals (APLS) United States $1.014B 0.00
Revance Therapeutics (RVNC) United States $0.990B 0.00
AVROBIO (AVRO) United States $0.985B 0.00
Amarin (AMRN) Ireland $0.865B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.858B 0.00
Dynavax Technologies (DVAX) United States $0.833B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.794B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.785B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.782B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.773B 0.00
Kura Oncology (KURA) United States $0.752B 0.00
Heska (HSKA) United States $0.740B 63.68
InflaRx (IFRX) Germany $0.735B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.732B 0.00
Cara Therapeutics (CARA) United States $0.724B 0.00
Aptinyx (APTX) United States $0.720B 0.00
Geron (GERN) United States $0.718B 0.00
Epizyme (EPZM) United States $0.709B 0.00
ANI Pharmaceuticals (ANIP) United States $0.674B 13.38
Eidos Therapeutics (EIDX) United States $0.666B 0.00
UNITY Biotechnology (UBX) $0.658B 0.00
Viking Therapeutics (VKTX) United States $0.648B 0.00
Abeona Therapeutics (ABEO) United States $0.623B 0.00
Anika Therapeutics (ANIK) United States $0.620B 26.08
UROGEN PHARMA (URGN) Israel $0.613B 0.00
Fate Therapeutics (FATE) United States $0.607B 0.00
Prothena (PRTA) Ireland $0.606B 0.00
Sorrento Therapeutics (SRNE) United States $0.595B 0.00
AC Immune SA (ACIU) Switzerland $0.594B 0.00
Verastem (VSTM) United States $0.590B 0.00
Mesoblast (MESO) Australia $0.574B 0.00
Arcus Biosciences (RCUS) United States $0.546B 0.00
Replimune (REPL) United States $0.531B 0.00
Senesco Technologies (ELOX) United States $0.527B 0.00
Vericel (VCEL) United States $0.527B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.522B 0.00
Novavax (NVAX) United States $0.520B 0.00
Kindred Biosciences (KIN) United States $0.512B 0.00
Arbutus Biopharma (ABUS) Canada $0.510B 0.00
Five Prime Therapeutics (FPRX) United States $0.493B 0.00
Stemline Therapeutics (STML) United States $0.477B 0.00
ObsEva SA (OBSV) Switzerland $0.474B 0.00
BeyondSpring (BYSI) United States $0.462B 0.00
MiMedx (MDXG) United States $0.453B 19.43
Zymeworks (ZYME) Canada $0.453B 0.00
Unum Therapeutics (UMRX) United States $0.442B 0.00
Zealand Pharma (ZEAL) Denmark $0.431B 0.00
Aduro Biotech (ADRO) United States $0.427B 0.00
Merus (MRUS) Netherlands $0.418B 0.00
Magenta Therapeutics (MGTA) United States $0.417B 0.00
Evelo Biosciences (EVLO) United States $0.416B 0.00
Inovio Pharmaceuticals (INO) United States $0.411B 0.00
GTx (GTXI) United States $0.407B 0.00
MediciNova (MNOV) United States $0.400B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.386B 0.00
Cytokineticsorporated (CYTK) United States $0.385B 0.00
Syros Pharmaceuticals (SYRS) United States $0.384B 0.00
Albireo Pharma (ALBO) United States $0.379B 0.00
Vital Therapies (VTL) United States $0.375B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.375B 0.00
Sinovac Biotech (SVA) China $0.367B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.366B 0.00
RA PHARMCTL INC (RARX) United States $0.355B 0.00
Scholar Rock Holding (SRRK) United States $0.351B 0.00
PDL BioPharma (PDLI) United States $0.346B 4.86
Cellular Biomedicine (CBMG) United States $0.346B 0.00
Seres Therapeutics (MCRB) United States $0.331B 0.00
Adverum Biotechnologies (ADVM) United States $0.329B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.321B 0.00
BioTime (BTX) United States $0.321B 0.00
Kezar Life Sciences (KZR) United States $0.319B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.319B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.314B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.300B 0.00
Constellation Pharmaceuticals (CNST) United States $0.297B 0.00
Mersana Therapeutics (MRSN) United States $0.296B 0.00
Kala Pharmaceuticals (KALA) United States $0.293B 0.00
ResTORbio (TORC) United States $0.292B 0.00
Strongbridge Biopharma (SBBP) United States $0.292B 0.00
Selecta Biosciences (SELB) United States $0.291B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.289B 0.00
Celyad SA (CYAD) Belgium $0.287B 0.00
Athersys (ATHX) United States $0.284B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.277B 0.00
Osiris Therapeutics (OSIR) United States $0.276B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.276B 0.00
ADMA Biologics Inc (ADMA) United States $0.271B 0.00
Cohbar (CWBR) United States $0.268B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.266B 0.00
Kadmon Holdings (KDMN) United States $0.265B 0.00
ChromaDex (CDXC) United States $0.264B 0.00
Celcuity (CELC) United States $0.263B 0.00
NantKwest (NK) United States $0.257B 0.00
Axovant Sciences (AXON) United Kingdom $0.256B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.256B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.242B 0.00
MeiraGTx Holdings (MGTX) United States $0.235B 0.00
Idera Pharmaceuticals (IDRA) United States $0.231B 0.00
Clearside Biomedical (CLSD) United States $0.231B 0.00
Allena Pharmaceuticals (ALNA) United States $0.229B 0.00
Liquidia Technologies (LQDA) United States $0.224B 0.00
Kamada (KMDA) Israel $0.221B 17.19
Agenus (AGEN) United States $0.203B 0.00
Menlo Therapeutics (MNLO) United States $0.202B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.201B 0.00
Spero Therapeutics (SPRO) United States $0.199B 0.00
Enzo Biochem (ENZ) United States $0.194B 0.00
Synlogic (SYBX) United States $0.194B 0.00
Palatin Technologies (PTN) United States $0.190B 7.35
TOCAGEN INC (TOCA) United States $0.182B 0.00
Signal Genetics (MGEN) United States $0.181B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) $0.180B 0.00
Protagonist Therapeutics (PTGX) United States $0.176B 0.00
MannKind (MNKD) United States $0.173B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.173B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.171B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.170B 0.00
Cue Biopharma (CUE) United States $0.166B 0.00
Krystal Biotech (KRYS) United States $0.166B 0.00
Mustang Bio (MBIO) United States $0.162B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.162B 0.00
OVID THERAPEUTC (OVID) United States $0.161B 0.00
BioDelivery Sciences (BDSI) United States $0.158B 0.00
XBiotech (XBIT) United States $0.158B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.157B 0.00
Compugen (CGEN) Israel $0.156B 0.00
XOMA (XOMA) United States $0.156B 16.42
Pluristem Therapeutics (PSTI) Israel $0.141B 0.00
Intec Pharma (NTEC) Israel $0.140B 0.00
Cerecor (CERC) United States $0.136B 16.79
BioXcel Therapeutics (BTAI) United States $0.135B 0.00
Provention Bio (PRVB) United States $0.132B 0.00
Motif Bio Plc (MTFB) United States $0.129B 0.00
VBI Vaccines (VBIV) United States $0.127B 0.00
Monster Digital (INNT) United States $0.127B 0.00
Organovo Holdings (ONVO) United States $0.127B 0.00
Anavex Life Sciences (AVXL) United States $0.127B 0.00
Catalyst Biosciences (CBIO) United States $0.122B 0.00
Cidara Therapeutics (CDTX) United States $0.122B 0.00
Trevena (TRVN) United States $0.122B 0.00
Checkpoint Therapeutics (CKPT) United States $0.121B 0.00
Aptevo Therapeutics (APVO) United States $0.119B 0.00
Cocrystal Pharma (COCP) United States $0.114B 0.00
PSivida (EYPT) United States $0.113B 0.00
Tapimmune (TPIV) United States $0.113B 0.00
Fortress Biotech (FBIO) United States $0.109B 0.00
Pfenex (PFNX) United States $0.108B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.106B 0.00
Leap Therapeutics (LPTX) United States $0.105B 0.00
Aptose Biosciences (APTO) Canada $0.105B 0.00
NewLink Genetics (NLNK) United States $0.105B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.100B 0.00
Orgenesis (ORGS) United States $0.100B 0.00
Asterias Biotherapeutics (AST) United States $0.097B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.092B 0.00
Eleven Biotherapeutics (SESN) United States $0.091B 0.00
Alcobra (ARCT) Israel $0.086B 0.00
Ophthotech (OPHT) United States $0.086B 0.56
Proteostasis Therapeutics (PTI) United States $0.085B 0.00
OncoSec Medical (ONCS) United States $0.083B 0.00
Sophiris Bio (SPHS) United States $0.083B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.081B 0.00
Advaxis (ADXS) United States $0.079B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.079B 0.00
Oncolytics Biotech (ONCY) Canada $0.079B 0.00
ScPharmaceuticals (SCPH) United States $0.078B 0.00
Histogenics (HSGX) United States $0.078B 0.00
Applied Genetic Technologies (AGTC) United States $0.074B 0.00
Protalix BioTherapeutics (PLX) Israel $0.074B 0.00
Evogene (EVGN) Israel $0.072B 0.00
Celldex Therapeutics (CLDX) United States $0.070B 0.00
VIVUS (VVUS) United States $0.069B 0.00
Prima BioMed (IMMP) Australia $0.068B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.068B 0.00
Alimera Sciences (ALIM) United States $0.067B 0.00
Axsome Therapeutics (AXSM) United States $0.063B 0.00
Neothetics (EVFM) United States $0.061B 0.00
Novelion Therapeutics (NVLN) Canada $0.060B 0.00
Entera Bio (ENTX) Israel $0.057B 0.00
VolitionRX (VNRX) Singapore $0.057B 0.00
Eyenovia (EYEN) United States $0.056B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Curis (CRIS) United States $0.051B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.050B 0.00
Caladrius Biosciences (CLBS) United States $0.050B 0.00
Zosano Pharma (ZSAN) United States $0.049B 0.00
CorMedix Inc (CRMD) United States $0.045B 0.00
Moleculin Biotech (MBRX) United States $0.045B 0.00
Celsion (CLSN) United States $0.044B 0.00
Chiasma (CHMA) United States $0.043B 0.00
Proteon Therapeutics (PRTO) United States $0.041B 0.00
AZURRX BIOPHARM (AZRX) United States $0.041B 0.00
VTv Therapeutics (VTVT) United States $0.040B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.038B 0.00
Bellerophon Therapeutics (BLPH) United States $0.038B 0.00
GENPREX INC (GNPX) United States $0.038B 0.00
CytRx (CYTR) United States $0.038B 0.00
TRACON Pharmaceuticals (TCON) United States $0.036B 0.00
Aileron Therapeutics (ALRN) United States $0.033B 0.00
BioPharmX (BPMX) United States $0.032B 0.00
AquaBounty Technologies (AQB) United States $0.032B 0.00
AEterna Zentaris (AEZS) United States $0.031B 62.00
Benitec Biopharma (BNTC) Australia $0.029B 0.00
OvaScience (OVAS) United States $0.029B 0.00
VistaGen Therapeutics (VTGN) United States $0.029B 0.00
Vical (VICL) United States $0.028B 0.00
Oncobiologics (ONS) United States $0.027B 0.00
Edge Therapeutics (EDGE) United States $0.027B 0.00
Arsanis (ASNS) United States $0.027B 0.00
Adial Pharmaceuticals (ADIL) United States $0.025B 0.00
Cellect Biotechnology (APOP) Israel $0.025B 0.00
Cel-Sci (CVM) United States $0.024B 0.00
Soligenix (SNGX) United States $0.024B 0.00
Cleveland BioLabs (CBLI) United States $0.023B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.022B 0.00
Gemphire Therapeutics (GEMP) United States $0.022B 0.00
ATyr Pharma (LIFE) United States $0.020B 0.00
RestorGenex (DFFN) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Titan Pharmaceuticals (TTNP) United States $0.019B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.018B 0.00
Prana Biotechnology (PRAN) Australia $0.018B 0.00
AmpliPhi Biosciences (APHB) United States $0.018B 0.00
Neuralstem (CUR) United States $0.018B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
TrovaGene (TROV) United States $0.014B 0.00
Hemispherx BioPharma (HEB) United States $0.014B 0.00
Therapix Biosciences (TRPX) Israel $0.013B 6.55
Cerulean Pharma (DARE) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
Flex Pharma (FLKS) United States $0.011B 0.00
Synthetic Biologics (SYN) United States $0.011B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.009B 0.00
ARCA Biopharma (ABIO) United States $0.009B 0.00
Tenax Therapeutics (TENX) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Galena Biopharma (SLS) United States $0.008B 0.00
IBio (IBIO) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.004B 0.00
Oragenics (OGEN) United States $0.003B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.002B 0.00
Aytu Bioscience (AYTU) United States $0.001B 0.00